Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism.

Spencer FA, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker RC, Goldberg RJ.

J Gen Intern Med. 2006 Jul;21(7):722-7.

2.

Prevention of venous thromboembolism in the geriatric patient.

Jaffer AK, Brotman DJ.

Clin Geriatr Med. 2006 Feb;22(1):93-111, ix. Review.

PMID:
16377469
3.

Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.

Kahn SR, Morrison DR, Cohen JM, Emed J, Tagalakis V, Roussin A, Geerts W.

Cochrane Database Syst Rev. 2013 Jul 16;(7):CD008201. doi: 10.1002/14651858.CD008201.pub2. Review.

PMID:
23861035
4.

Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review.

Langlois NJ, Wells PS.

Thromb Haemost. 2003 Jul;90(1):17-26. Review.

PMID:
12876621
5.

[Venous thromboembolism and cancer].

Pavic M, Debourdeau P, Aletti M, Farge-Bancel D, Rousset H.

Rev Med Interne. 2006 Apr;27(4):313-22. Epub 2005 Dec 29. Review. French.

PMID:
16414153
6.
7.

Management of venous thromboembolism in the elderly.

Spyropoulos AC, Merli G.

Drugs Aging. 2006;23(8):651-71. Review.

PMID:
16964988
8.

Epidemiology of venous thromboembolism.

Kearon C.

Semin Vasc Med. 2001;1(1):7-26. Review.

PMID:
15199510
9.
10.
11.

Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.

Samama MM, Dahl OE, Quinlan DJ, Mismetti P, Rosencher N.

Haematologica. 2003 Dec;88(12):1410-21. Review.

12.

Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update.

Falciani M, Imberti D, Prisco D.

Intern Emerg Med. 2006;1(4):273-8. Review.

PMID:
17217148
13.

Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.

Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH.

Am J Med. 2005 May;118(5):503-14. Review.

PMID:
15866253
15.
16.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
17.

[Evaluation of the risk of venous thromboembolism in the medical patients].

Mismetti P, Juillard-Delsart D, Tardy B, Laporte-Simitsidis S, Decousus H.

Therapie. 1998 Nov-Dec;53(6):565-70. Review. French.

PMID:
10070234
18.

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG.

Thromb Haemost. 2005 Oct;94(4):750-9. Review.

PMID:
16270626
19.

Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.

Sullivan SD, Kahn SR, Davidson BL, Borris L, Bossuyt P, Raskob G.

Pharmacoeconomics. 2003;21(7):477-96. Review.

PMID:
12696988
20.

Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

Verso M, Agnelli G.

J Clin Oncol. 2003 Oct 1;21(19):3665-75. Review.

PMID:
14512399

Supplemental Content

Support Center